Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Details for Australian Patent Application No. 2001269943 (hide)

Owner Bristol-Myers Squibb Company

Inventors Giese, Soren; Li, Wenying; Balog, James, Aaron; Hanson, Ronald L.; Pickering, Dacia A.; Fura, Aberra; Salvati, Mark E.; Patel, Ramesh N.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001269943

PCT Pub. Number WO02/24702

Priority 60284438 18.04.01 US; 60233519 19.09.00 US; 60284730 18.04.01 US

Filing date 20 June 2001

Wipo publication date 2 April 2002

Acceptance publication date 9 November 2006

International Classifications

C07D 491/08 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/00 (2006.01)

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/655 (2006.01) - Azo (NN), diazo (N), azoxy (NON or N(O)N), azido (N) or diazoamino (NNN) compounds

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

C07D 471/18 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 487/18 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 491/18 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 491/22 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 495/18 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

9 November 2006 Application Accepted

  Published as AU-B-2001269943

8 March 2007 Standard Patent Sealed

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001269944-Protein expression profiling

2001269942-Graft fixation using a screw or plug against suture or tissue